Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 894Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

EDITORIAL

Investigator initiated trials (IITs)

Suvarna Viraj

Year : 2012| Volume: 3| Issue : 4 | Page no: 119-121

   This article has been cited by
 
1 The Invisible Hand of Industry
X. Mona Guo, Emma L. Barber
Clinical Obstetrics & Gynecology. 2022; 65(2): 260
[Pubmed]  [Google Scholar] [DOI]
2 Challenges of independent clinical research
Javier P. Gisbert,María Chaparro
Gastroenterología y Hepatología (English Edition). 2021;
[Pubmed]  [Google Scholar] [DOI]
3 A Bayesian response-adaptive dose-finding and comparative effectiveness trial
Anna Heath,Maryna Yaskina,Petros Pechlivanoglou,David Rios,Martin Offringa,Terry P Klassen,Naveen Poonai,Eleanor Pullenayegum
Clinical Trials. 2021; 18(1): 61
[Pubmed]  [Google Scholar] [DOI]
4 Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Anette Blümle,Katharina Wollmann,Karin Bischoff,Philipp Kapp,Szimonetta Lohner,Edris Nury,Kai Nitschke,Jasmin Zähringer,Gerta Rücker,Martin Schumacher
BMC Medical Research Methodology. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
5 Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study
Jonathan A Cook,Mathew Baldwin,Cushla Cooper,Navraj S Nagra,Joanna C Crocker,Molly Glaze,Gemma Greenall,Amar Rangan,Lucksy Kottam,Jonathan L Rees,Dair Farrar-Hockley,Naomi Merritt,Sally Hopewell,David Beard,Michael Thomas,Melina Dritsaki,Andrew J Carr
Health Technology Assessment. 2021; 25(13): 1
[Pubmed]  [Google Scholar] [DOI]
6 Practices and Attitudes of Swiss Stakeholders Regarding Investigator-Initiated Clinical Trial Funding Acquisition and Cost Management
Stuart McLennan,Alexandra Griessbach,Matthias Briel
JAMA Network Open. 2021; 4(6): e2111847
[Pubmed]  [Google Scholar] [DOI]
7 A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials
Benjamin Speich,Patricia Logullo,Stefanie Deuster,Ioana R. Marian,Joanna Moschandreas,Ala Taji Heravi,Viktoria Gloy,Matthias Briel,Sally Hopewell
Journal of Clinical Epidemiology. 2021; 131: 70
[Pubmed]  [Google Scholar] [DOI]
8 Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials
Carolin Haeussler,Anne Assmus
Research Policy. 2020; : 104155
[Pubmed]  [Google Scholar] [DOI]
9 Current clinical trials on breast cancer in China: A systematic literature review
Ying Fan,Binghe Xu
Cancer. 2020; 126(S16): 3811
[Pubmed]  [Google Scholar] [DOI]
10 Signal Management in Pharmacovigilance: A Review of Activities and Case Studies
Paul Beninger
Clinical Therapeutics. 2020; 42(6): 1110
[Pubmed]  [Google Scholar] [DOI]
11 Retos y desafíos de la investigación clínica independiente
Javier P. Gisbert,María Chaparro
Gastroenterología y Hepatología. 2020;
[Pubmed]  [Google Scholar] [DOI]
12 Investigator clinical trials: How can we ask the question?
Jean-François Schved
Haemophilia. 2020; 26(S3): 20
[Pubmed]  [Google Scholar] [DOI]
13 Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles
Ko Un Park,Eleftherios P. Mamounas,Matthew H. G. Katz,Gary Unzeitig,Darren Carpizo,Y. Nancy You,Amanda Francescatti,Kelly K. Hunt,Judy C. Boughey
Annals of Surgical Oncology. 2020;
[Pubmed]  [Google Scholar] [DOI]
14 Investigator-initiated clinical trials in the Czech Republic - overview for 2004-2007
Lenka Horavová,Katerina Nebeská,Jana Merhautová,Regina Demlová,Lenka Soucková
Klinická farmakologie a farmacie. 2019; 32(4): 3
[Pubmed]  [Google Scholar] [DOI]
15 Determination of a novel antifibrotic small molecule GDC-3280 in human plasma and urine by liquid chromatography tandem mass spectrometry to support its first-in-human clinical trial
Jianshuang Wang,Michael Van Parys,Lin Pan,Yuan Chen,Dorothy Cheung,Janine McKnight,Dennis Milanowski,Xiao Ding,Brian Dean
Biomedical Chromatography. 2019; 33(4): e4482
[Pubmed]  [Google Scholar] [DOI]
16 Mechanisms and funding opportunities in genitourinary cancer clinical research
Christopher W. Ryan
Urologic Oncology: Seminars and Original Investigations. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 Pharmaceutical industry contribution to research is essential but full transparency and guidelines are required
Amir Lass
Human Reproduction. 2017; 32(10): 2147
[Pubmed]  [Google Scholar] [DOI]
18 Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data
Oktay Yildirim,Matthias Gottwald,Peter Schüler,Martin C. Michel
Frontiers in Pharmacology. 2016; 7
[Pubmed]  [Google Scholar] [DOI]
19 Fellow-Initiated Clinical Trials
Yan Liu,Xuming Dai
Journal of the American College of Cardiology. 2015; 66(3): 324
[Pubmed]  [Google Scholar] [DOI]
20 Extension of the primary care research object model (PCROM) as clinical research information model (CRIM) for the “learning healthcare system”
Wolfgang Kuchinke,Töresin Karakoyun,Christian Ohmann,Theodoros N Arvanitis,Adel Taweel,Brendan C Delaney,Stuart M Speedie
BMC Medical Informatics and Decision Making. 2014; 14(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article